T1	Participants 32 66	people at high cardiovascular risk
T2	Participants 379 432	HOPE (Heart Outcomes and Prevention Evaluation) study
T3	Participants 482 560	9297 participants, including 3577 with diabetes and 1956 with microalbuminuria
